Shuli Qu

627 total citations
31 papers, 403 citations indexed

About

Shuli Qu is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Economics and Econometrics. According to data from OpenAlex, Shuli Qu has authored 31 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Economics and Econometrics. Recurrent topics in Shuli Qu's work include Diabetes Treatment and Management (5 papers), Diabetes Management and Research (4 papers) and Healthcare Policy and Management (4 papers). Shuli Qu is often cited by papers focused on Diabetes Treatment and Management (5 papers), Diabetes Management and Research (4 papers) and Healthcare Policy and Management (4 papers). Shuli Qu collaborates with scholars based in China, United States and United Kingdom. Shuli Qu's co-authors include Sajal K. Chattopadhyay, Nicolaas P. Pronk, Ping Zhang, Rui Li, Edward W. Gregg, David P. Hopkins, Ann Albright, Lihong Ren, Ye Liu and Suodi Zhai and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and Annals of Oncology.

In The Last Decade

Shuli Qu

29 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shuli Qu China	11	109	64	64	60	56	31	403
Christophe Bonaldi France	11	137 1.3×	36 0.6×	72 1.1×	58 1.0×	11 0.2×	33	375
Małgorzata Pikala Poland	14	35 0.3×	180 2.8×	79 1.2×	161 2.7×	31 0.6×	56	571
Erin Keast United States	15	18 0.2×	118 1.8×	67 1.0×	69 1.1×	39 0.7×	49	640
Antônio José Leal Costa Brazil	15	258 2.4×	150 2.3×	64 1.0×	64 1.1×	39 0.7×	53	619
Margarida Borges Portugal	13	60 0.6×	31 0.5×	88 1.4×	42 0.7×	22 0.4×	49	474
R.A. Lahti Finland	10	33 0.3×	99 1.5×	85 1.3×	63 1.1×	56 1.0×	13	472
Yvonne L. Eaglehouse United States	13	70 0.6×	75 1.2×	50 0.8×	84 1.4×	24 0.4×	36	435
Mei‐Ju Ko Taiwan	14	80 0.7×	37 0.6×	70 1.1×	30 0.5×	39 0.7×	34	760
Robert Feldman United States	12	104 1.0×	103 1.6×	22 0.3×	46 0.8×	17 0.3×	23	452
Richard Crilly Canada	12	41 0.4×	60 0.9×	61 1.0×	46 0.8×	51 0.9×	21	493

Countries citing papers authored by Shuli Qu

Since Specialization

Citations

This map shows the geographic impact of Shuli Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuli Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuli Qu more than expected).

Fields of papers citing papers by Shuli Qu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuli Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuli Qu. The network helps show where Shuli Qu may publish in the future.

Co-authorship network of co-authors of Shuli Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuli Qu. A scholar is included among the top collaborators of Shuli Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuli Qu. Shuli Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yanpeng, et al.. (2025). Proactive operational strategy of thermal energy storage tank in an industrial multi-chiller system based on chilled water flow difference between supply and demand sides. Energy. 319. 134752–134752. 4 indexed citations

Li, Yanpeng, et al.. (2025). Energy savings of multi-chiller systems comprising hybrid-type compressors combined with thermal energy storage technology: Focusing on compressor isentropic efficiency. Energy. 325. 136139–136139. 2 indexed citations

Guo, Yi, Li D, Jing Lin, et al.. (2024). 872P Safety and efficacy of toripalimab combined with cetuximab in PD-L1 positive untreated recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): A phase Ib/II study. Annals of Oncology. 35. S625–S625.

Wu, Jing, Jian Ming, Shuli Qu, et al.. (2023). HPR51 Should Volume-Based Procurement Price of Comparator be Referenced for Innovative Drugs in National Reimbursement Drug List Negotiation in China?. Value in Health. 26(6). S220–S220. 1 indexed citations

Zhao, Xinran, Jian Ming, Shuli Qu, et al.. (2021). Cost-Effectiveness of Flash Glucose Monitoring for the Management of Patients with Type 1 and Patients with Type 2 Diabetes in China. Diabetes Therapy. 12(12). 3079–3092. 13 indexed citations

Qin, Xiaojian, Dingwei Ye, Chengyuan Gu, et al.. (2021). Prostate Cancer Screening Using Prostate-Specific Antigen Tests in a High-Risk Population in China: A Cost-Utility Analysis. Current Therapeutic Research. 95. 100653–100653. 1 indexed citations

Qu, Shuli, Xuedan You, Lijiao Wang, et al.. (2021). Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China. npj Primary Care Respiratory Medicine. 31(1). 28–28. 10 indexed citations

Men, Peng, et al.. (2020). Lixisenatide for Type 2 Diabetes Mellitus Patients Inadequately Controlled on Oral Antidiabetic Drugs: A Mixed-Treatment Comparison Meta-analysis and Cost–Utility Analysis. Diabetes Therapy. 11(8). 1745–1755. 6 indexed citations

Men, Peng, et al.. (2019). Comparison of lixisenatide in combination with basal insulin vs other insulin regimens for the treatment of patients with type 2 diabetes inadequately controlled by basal insulin: Systematic review, network meta‐analysis and cost‐effectiveness analysis. Diabetes Obesity and Metabolism. 22(1). 107–115. 14 indexed citations

10.

Wang, Ke, et al.. (2019). Comparison of Characteristics Between Chinese Patients Taking Glucagon-like Peptide 1 Receptor Agonists and Insulin: A Cross-sectional Database Analysis. Clinical Therapeutics. 41(10). 2057–2065.

11.

Hu, Xin, et al.. (2019). Abiraterone acetate and docetaxel with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer in China: an indirect treatment comparison and cost analysis. Cost Effectiveness and Resource Allocation. 17(1). 27–27. 8 indexed citations

12.

Liu, Maobai, Shuli Qu, Yanjun Liu, Xingxing Yao, & Wei Jiang. (2019). Comparative clinical effects and cost–effectiveness of maximum androgen blockade, docetaxel with androgen deprivation therapy and ADT alone for the treatment of mHSPC in China. Journal of Comparative Effectiveness Research. 8(11). 865–877. 6 indexed citations

13.

Bao, Yun, Gang Zhao, Shuli Qu, et al.. (2019). A Caprini Risk Score-Based Cost-Effectiveness Analysis of Enoxaparin for the Thromboprophylaxis of Patients After Nonorthopedic Surgery in a Chinese Healthcare Setting. Clinical Drug Investigation. 40(2). 161–171. 7 indexed citations

14.

Foos, V., Ke Wang, Phil McEwan, et al.. (2018). Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling Approach. Value in Health Regional Issues. 18. 36–46. 14 indexed citations

15.

Hu, Xin, Xingxing Yao, Yanjun Liu, et al.. (2018). Comparison of abiraterone acetate and docetaxel with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer (mHSPC): An updated network meta-analysis and cost minimization analysis in China.. Journal of Clinical Oncology. 36(15_suppl). e17008–e17008. 1 indexed citations

16.

Hahn, Robert A., Krista K. Proia, Benedict I. Truman, et al.. (2015). Out-of-School-Time Academic Programs to Improve School Achievement. Journal of Public Health Management and Practice. 21(6). 594–608. 21 indexed citations

17.

Sipe, Theresa Ann, Ramona Finnie, Shuli Qu, et al.. (2015). Effects of Mental Health Benefits Legislation. American Journal of Preventive Medicine. 48(6). 755–766. 19 indexed citations

18.

Qu, Shuli, Sajal K. Chattopadhyay, & Robert A. Hahn. (2015). High School Completion Programs. Journal of Public Health Management and Practice. 22(3). E47–E56. 4 indexed citations

19.

Bergen, Gwen, Shuli Qu, Ruth A. Shults, et al.. (2014). Publicized Sobriety Checkpoint Programs. American Journal of Preventive Medicine. 46(5). 529–539. 48 indexed citations

20.

Liu, Ye, et al.. (2012). The GC, CYP2R1 and DHCR7 genes are associated with vitamin D levels in northeastern Han Chinese children. Swiss Medical Weekly. 142(2930). w13636–w13636. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact